Maternal Abdominal Morphology Assessment
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-54
SponsorUniversity of Texas at Austin
About this trial
Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes.
The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.
Eligibility criteria
Qualifiers
Pregnant women, with a singleton gestation
Age 18 - 54 years at screening
Gestational age < 14 weeks
Willing to commit to 1 year postpartum follow up
Disqualifiers
Presence of any mechanically or magnetically activated implants
Claustrophobia
Other contraindication for MRI
BMI ≥ 38.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
87 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Texas at Austin
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov